← Leaderboards
Jennings C Luu
Case Western Reserve University
$209,456
Attributed
$209,456
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$209,456 · 1
By mechanism
F30$209,456 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Paul S Park$7,385,674
- Focco Van Den Akker$5,732,564
- Arthur J McCullough$9,778,555
- Jianmin Cui$14,464,859
- William P Schilling$5,014,770
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAdverse EffectsAgingApoptoticAge Related Macular DegenerationBiologyBlindnessCaffeineCardiovascular PhysiologyCell DeathBindingCell TypeChronicCombatCombined Modality TherapyComputer AssistedConsumptionCyclic AmpCyclic GmpCyclic NucleotidesCytoprotectionDoseCell SurvivalDrug Design
Grant awards (4)
Identification of novel phosphodiesterase (PDE)-modulating compounds and characterization of associated cytoprotective pathways in lightdamagedretina$53,974
F30 · FY2024 · EY · contact PI
Identification of novel phosphodiesterase (PDE)-modulating compounds and characterization of associated cytoprotective pathways in lightdamagedretina$52,694
F30 · FY2023 · EY · contact PI
Identification of novel phosphodiesterase (PDE)-modulating compounds and characterization of associated cytoprotective pathways in lightdamagedretina$51,752
F30 · FY2022 · EY · contact PI
Identification of novel phosphodiesterase (PDE)-modulating compounds and characterization of associated cytoprotective pathways in lightdamagedretina$51,036
F30 · FY2021 · EY · contact PI